Amerigen Pharmaceuticals
Amerigen Pharmaceuticals develops, manufactures, and distributes generic pharmaceutical products.
Launch date
Employees
Market cap
-
Enterprise valuation
€127—191m (Dealroom.co estimates Jan 2015.)
Lyndhurst New Jersey (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$35.0m | Late VC | ||
| Total Funding | €31.8m | ||
Recent News about Amerigen Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.